Manifestation of rheumatoid arthritis after transsphenoidal surgery in a patient with acromegaly

被引:4
作者
Miyoshi, Tomoko
Otsuka, Fumio
Kawabata, Tomoko
Inagaki, Kenichi
Mukai, Tomoyuki
Kawashima, Masaniori
Ogura, Toshio
Yamamura, Masahiro
Sei, Tetsuro
Makino, Hirofumi
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama 7008558, Japan
关键词
acromegaly; arthropathy; growth hormone; pituitary adenoma; rheumatoid arthritis;
D O I
10.1507/endocrj.K06-043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acromegalic arthropathy is one of the most frequent manifestations occurring in acromegaly patients. In contrast, rheumatoid arthritis (RA) is a rare clinical complication in acromegaly patients. Here, we report a 70-year-old Japanese woman with acromegaly, who complained of bilateral finger stiffness and polyarthralgia two months after transsphenoidal surgery of a growth hormone (GH)-secreting pituitary adenoma. Postoperative levels of serum GH and insulin-like growth factor-1 (IGF-1) were markedly decreased without any secretory deficiency of other anterior pituitary hormones. Hand X-ray did not show typical RA changes; however, erosive changes in carpal bones were clearly detected by magnetic resonance imaging with gadolinium enhancement. Based on the levels of serological markers in the patient following surgery including C-reactive protein, rheumatoid factor and matrix metalloproteinase-3, anti-rheumatic therapy was subsequently commenced. Regardless of the levels of GH and IGF-1, acromegaly patients frequently complain about joint-related symptoms even after remission. Therefore, careful observation of bone erosive changes and immunological activity in acromegaly patients is required when joint-related symptoms persist.
引用
收藏
页码:621 / 625
页数:5
相关论文
共 21 条
  • [1] Acromegalic arthropathy
    Barkan A.L.
    [J]. Pituitary, 2001, 4 (4) : 263 - 264
  • [2] Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life
    Biermasz, NR
    Pereira, AM
    Smit, JWA
    Romijn, JA
    Roelfsema, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) : 2731 - 2739
  • [3] ACROMEGALIC ARTHROPATHY
    BLUESTONE, R
    BYWATERS, EG
    HARTOG, M
    HOLT, PJL
    HYDE, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1971, 30 (03) : 243 - +
  • [4] Metalloproteinases (MMPs-2,-3) are involved in TGF-β and IGF-1-induced bone defect healing in 20-month-old female rats
    Blumenfeld, I
    Srouji, S
    Peled, M
    Livne, E
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2002, 35 (01) : 59 - 69
  • [5] Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age
    Colao, A
    Spiezia, S
    Di Somma, C
    Pivonello, R
    Marzullo, P
    Rota, F
    Musella, T
    Auriemma, RS
    De Martino, MC
    Lombardi, G
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (05) : 440 - 448
  • [6] Reversibility of joint thickening in acromegalic patients:: An ultrasonography study
    Colao, A
    Marzullo, P
    Vallone, G
    Marinò, V
    Annecchino, M
    Ferone, D
    De Brasi, D
    Scarpa, R
    Oriente, P
    Lombardi, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06) : 2121 - 2125
  • [7] Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly
    Colao, A
    Cannavò, S
    Marzullo, P
    Pivonello, R
    Squadrito, S
    Vallone, G
    Almoto, B
    Bichisao, E
    Trimarchi, F
    Lombardi, G
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (01) : 31 - 38
  • [8] DETENBECK LC, 1973, CLIN ORTHOP RELAT R, P119
  • [9] ARTHROPATHY IN ACROMEGALIC PATIENTS BEFORE AND AFTER TREATMENT - A LONG-TERM FOLLOW-UP-STUDY
    DONS, RF
    ROSSELET, P
    PASTAKIA, B
    DOPPMAN, J
    GORDEN, P
    [J]. CLINICAL ENDOCRINOLOGY, 1988, 28 (05) : 515 - 524
  • [10] Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF-binding protein-3 complexes
    Fowlkes, JL
    Serra, DM
    Bunn, RC
    Thrailkill, KM
    Enghild, JJ
    Nagase, H
    [J]. ENDOCRINOLOGY, 2004, 145 (02) : 620 - 626